Dr. Yamamoto is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
101 The City Dr S
Orange, CA 92868Phone+1 714-456-8000Fax+1 714-456-7244
Education & Training
- University of South Florida MorsaniFellowship, Complex General Surgical Oncology, 2011 - 2014
- University of California (Irvine)Residency, Surgery, 2004 - 2011
- New York Medical CollegeClass of 2004
Certifications & Licensure
- CA State Medical License 2006 - 2026
- FL State Medical License 2011 - 2019
- American Board of Surgery Surgery
- American Board of Surgery Complex General Surgical Oncology
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Publications & Presentations
PubMed
- 27 citationsPredicting nodal status using dynamic contrast-enhanced magnetic resonance imaging in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy ...David Hsiang, Maki Yamamoto, Rita S. Mehta, Min-Ying Su, Choong Baick
Archives of Surgery. 2007-09-01 - 14 citationsPhase II study of pazopanib in combination with paclitaxel in patients with metastatic melanoma.John P. Fruehauf, Monica El-Masry, Katherine Osann, Basmina Parmakhtiar, Maki Yamamoto
Cancer Chemotherapy and Pharmacology. 2018-06-25 - 28 citationsSurgical management of recurrent ovarian cancer: The advantage of collaborative surgical management and a multidisciplinary approachElizabeth Burton, Dana M. Chase, Maki Yamamoto, Jayson de Guzman, David K. Imagawa
Gynecologic Oncology. 2011-01-01
Press Mentions
- Prospective, Multicenter Study Demonstrates That DecisionDx®-Melanoma Test Results Can Significantly Reduce the Number of Sentinel Lymph Node Biopsy (SLNB) Procedures Performed When Used Within the Context of Current GuidelinesFebruary 9th, 2023
- -Melanoma Test Results Can Significantly Reduce the Number of Sentinel Lymph Node Biopsy (SLNB) Procedures Performed When Used Within the Context of Current GuidelinesFebruary 9th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: